Medium-chain fatty acid nanoliposomes for easy energy supply

Nutrition

Volumn 27, Issue 6, 2011, Pages 700-706

  Liu, Wei ^a   Liu, Wei Lin ^a   Liu, Cheng Mei ^a   Liu, Jian Hua ^a   Yang, Shui Bing ^a   Zheng, Hui Juan ^a   Lei, Han Wu ^a   Ruan, Roger ^a   Li, Ti ^a   Tu, Zong Cai ^a   Song, Xin Yong ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Easy energy supply; High pressure microfluidization; Medium chain fatty acids; Nanoliposomes; Stability

Indexed keywords

GLYCOGEN; LACTIC ACID; LIPOSOME; MEDIUM CHAIN FATTY ACID; NANOCARRIER; NANOLIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG STABILITY; ENERGY RESOURCE; GLYCOGEN LIVER LEVEL; LACTATE BLOOD LEVEL; LOW DRUG DOSE; MALE; MICROFLUIDICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SWIMMING; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BLOOD UREA NITROGEN; DIETARY FATS; ENERGY INTAKE; FATTY ACIDS; GLYCOGEN; LACTIC ACID; LIPOSOMES; LIVER; MALE; MICE; MICE, INBRED BALB C; MICROFLUIDICS; NANOSTRUCTURES; NUTRITIVE VALUE; PARTICLE SIZE; PHYSICAL ENDURANCE; PHYSICOCHEMICAL PHENOMENA; PRESSURE; RANDOM ALLOCATION;

MUS;

EID: 79955614899     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2010.06.010     Document Type: Article

References (58)

1. Wolfram G. Medium-chain triglycerides (MCT) for total parenteral nutrition. World J Surg 1986, 10:33-37.
2. Guillot E., Vaugelade P., Lemarchali P., RéRat A. Intestinal absorption and liver uptake of medium-chain fatty acids in non-anaesthetized pigs. Br J Nutr 1993, 69:431-442.
3. Wiley J.H., Leveille G.A. Metabolic consequences of dietary medium-chain triglycerides in the rat. J Nutr 1973, 103:829-835.
4. Tsuji H., Kasai M., Takeuchi H., Nakamura M., Okazaki M., Kondo K. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr 2001, 131:2853-2859.
5. Bach A.C., Babayan V.K. Medium-chain triglycerides: an update. Am J Clin Nutr 1982, 36:950-962.
6. Megremis C.J. Medium-chain triglycerides: a nonconventional fat. Food Technol 1991, 45:108-110.
7. Decuypere J.A., Dierick N.A. The combined use of triacylglycerols containing medium-chain fatty acids and exogenous lipolytic enzymes as an alternative to in-feed antibiotics in piglets: concept, possibilities and limitations. An overview. Nutr Res Rev 2003, 16:193-210.
8. Mabayo R.T., Furuse M., Yang S.I., Okumura J. Medium-chain triacylglycerols enhance release of cholecystokinin in chicks. J Nutr 1992, 122:1702-1705.
9. Lin C.L., Chiang S.H., Lee H.F. Causes of reduced survival of neonatal pigs by medium-chain triglycerides: blood metabolite and behavioral activity approaches. J Anim Sci 1995, 73:2019-2025.
10. Brouns F., van der Vusse G.J. Utilization of lipids during exercise in human subjects: metabolic and dietary constraints. Br J Nutr 1998, 79:117-128.
11. Lasic D.D., Papahadjopoulos D. Liposomes revisited. Science 1995, 267:1275-1276.
12. Mozafari M.R., Mortazavi S.M. Nanoliposomes: from fundamentals to recent developments 2005, Trafford Publications, Oxford, UK.
13. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145-160.
14. + protects human endothelial cells from energy failure in a cell culture model of sepsis. Res Commun Mol Pathol Pharmacol 2001, 110:107-116.
15. Neveux N., De Bandt J.P., Chaumeil J.C., Cynober L. Hepatic preservation, liposomally entrapped adenosine triphosphate and nitric oxide production: a study of energy state and protein metabolism in the cold-stored rat liver. Scand J Gastroenterol 2002, 37:1057-1063.
16. Niibori K., Wroblewski K.P., Yokoyama H., Crestanello J.A., Whitman G.J. Bioenergetic effect of liposomal coenzyme Q10 on myocardial ischemia reperfusion injury. Biofactors 1999, 9:307-313.
17. Sorgi F.L., Huang L. Large scale production of DC-Chol cationic liposomes by microfluidization. Int J Pharm 1996, 144:131-139.
18. Awasthi V.D., Garcia D., Klipper R., Goins B.A., Phillips W.T. Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics. J Pharmacol Exp Ther 2004, 309:241-248.
19. Cho E.C., Lim H.J., Kim H.J., Son E.D., Choi H.J., Park J.H., et al. Role of pH-sensitive polymer-liposome complex in enhancing cellular uptake of biologically active drugs. Mater Sci Eng C 2009, 29:774-778.
20. Zheng S., Alkan-Onyuksel H., Beissinger R.L., Wasan D.T. Liposome microencapsulations without using any organic solvent. J Disper Sci Technol 1999, 20:1189-1203.
21. Feijoo S.C., Hayes W.W., Watson C.E., Martin J.H. Effects of Microfluidizer® technology on Bacillus licheniformis spores in ice cream mix. J Dairy Sci 1997, 80:2184-2187.
22. Liu W., Liu J.H., Xie M.Y., Liu C.M., Liu W.L., Wan J. Characterization and high-pressure microfluidization-induced activation of polyphenoloxidase from Chinese pear (Pyrus pyrifolia Nakai). J Agric Food Chem 2009, 57:5376-5380.
23. Takahashi M., Inafuku K., Miyagi T., Oku H., Wada K., Imura T., et al. Efficient preparation of liposomes encapsulating food materials using lecithins by a mechanochemical method. J Oleo Sci 2007, 56:35-42.
24. Barnadas-Rodríguez R., Sabés M. Factors involved in the production of liposomes with a high-pressure homogenizer. Int J Pharm 2001, 213:175-186.
25. Bangham A.D., Standish M.M., Watkins J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965, 13:238-252.
26. Mozafari M.R., Johnson C., Hatziantoniou S., Demetzos C. Nanoliposomes and their applications in food nanotechnology. J Liposome Res 2008, 18:309-327.
27. Liu W., Liu J.H., Liu C.M., Zhong Y.J., Liu W.L., Wan J. Activation and conformational changes of mushroom polyphenoloxidase by high pressure microfluidization treatment. Innov Food Sci Emerg 2009, 10:142-147.
28. Samman S., Chow J.W.Y., Foster M.J., Ahmad Z.I., Phuyal J.L., Petocz P. Fatty acid composition of edible oils derived from certified organic and conventional agricultural methods. Food Chem 2008, 109:670-674.
29. Chen Y., Kong L.D., Xia X., Kung H.F., Zhang L. Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the forced swimming test in mice. J Ethnopharmacol 2005, 96:451-459.
30. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
31. Hui Y.H., Huang N.H., Ebbert L., Bina H., Chiang A., Maples C., et al. Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs. J Pharmacol Toxicol Methods 2007, 56:256-264.
32. Thompson A.K., Singh H. Preparation of liposomes from milk fat globule membrane phospholipids using a microfluidizer. J Dairy Sci 2006, 89:410-419.
33. 3-O-toluyl-fluorouracil-loaded liposomes. Int J Pharm 2008, 353:243-250.
34. Takahashi M., Kitamoto D., Imura T., Oku H., Takara K., Wada K. Characterization and bioavailability of liposomes containing an ukon extract. Biosci Biotechnol Biochem 2008, 72:1199-1205.
35. Heurtault B., Saulnier P., Pech B., Proust J.E., Benoit J.P. Physico-chemical stability of colloidal lipid particles. Biomaterials 2003, 24:4283-4300.
36. DeLuca T., Kaszuba M., Mattison K. Optimizing silicone emulsion stability using zeta potential. Am Lab 2006, 38:14-15.
37. Cui J.X., Li C.L., Guo W.M., Li Y.H., Wang C.X., Zhang L. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?. J Control Rel 2007, 118:204-215.
38. Thompson A.K., Mozafari M.R., Singh H. The properties of liposomes produced from milk fat globule membrane material using different techniques. Lait 2007, 87:349-360.
39. Liu N., Park H.J. Chitosan-coated nanoliposome as vitamin E carrier. J Microencapsul 2009, 26:235-242.
40. Lagoueyte N., Paquin P. Effects of microfluidization on the functional properties of xanthan gum. Food Hydrocolloids 1998, 12:365-371.
41. Rogers J.A., Anderson K.E. The potential of liposomes in oral drug delivery. Crit Rev Ther Drug Carrier Syst 1998, 15:421-480.
42. Belluardo N., Westerblad H., Mudó G., Casabona A., Bruton J., Caniglia G., et al. Neuromuscular junction disassembly and muscle fatigue in mice lacking neurotrophin-4. Mol Cell Neurosci 2001, 18:56-67.
43. Lapvetelainen T., Tiihonen A., Koskela P., Nevalainen T., Lindblom J., Kiraly K., et al. Training a large number of laboratory mice using running wheels and analyzing running behavior by use of a computer-assisted system. Lab Anim Sci 1997, 47:172-179.
44. Siekmeier R., Scheuch G. Systemic treatment by inhalation of macromolecules-principles, problems, and examples. J Physiol Pharmacol 2008, 59:53-79.
45. Hettema E.H., Tabak H.F. Transport of fatty acids and metabolites across the peroxisomal membrane. Biochim Biophys Acta 2000, 1486:18-27.
46. Tang W.Y., hang Y.Z., Gao J., Ding X.Y., Gao S. The anti-fatigue effect of 20 (R)-ginsenoside Rg3 in mice by intranasally administration. Biol Pharm Bull 2008, 31:2024-2027.
47. Zhang Y., Yao X.B., Bao B.L., Zhang Y. Anti-fatigue activity of a triterpenoid-rich extract from Chinese bamboo shavings (Caulis bamfusae in taeniam). Phytother Res 2006, 20:872-876.
48. Tsopanakis C., Tsopanakis A. Stress hormonal factors, fatigue, and antioxidant responses to prolonged speed driving. Pharmacol Biochem Behav 1998, 60:747-751.
49. An H.J., Choi H.M., Park H.S., Han J.G., Lee E.H., Park Y.S., et al. Oral administration of hot water extracts of Chlorella vulgaris increases physical stamina in mice. Ann Nutr Metab 2006, 50:380-386.
50. Tamminga S. The effect of the supply of rumen degradable protein and metabolisable protein on negative energy balance and fertility in dairy cows. Anim Reprod Sci 2006, 96:227-239.
51. Westerblad H., Allen D.G., Lännergren J. Muscle fatigue: lactic acid or inorganic phosphate the major cause?. News Physiol Sci 2002, 17:17-21.
52. Sahlin K., Tonkonogi M., Soderlund K. Energy supply and muscle fatigue in humans. Acta Physiol Scand 1998, 162:261-266.
53. Dorchy H. Sports and type I diabetes: personal experience. Rev Med Brux 2002, 23:211-217.
54. Ma L., Cai D.L., Li H.X., Bende T., Song L.H., Wang Y. Anti-fatigue effects of salidroside in mice. J Med Coll PLA 2008, 23:88-93.
55. Bergström J., Hultman E. A study of the glycogen metabolism during exercise in man. Scand J Clin Lab Invest 1967, 19:218-228.
56. Azevedo J.L., Linderman J.K., Lehman S.L., Brooks G.A. Training decreases muscle glycogen turnover during exercise. Eur J Appl Physiol 1998, 78:479-486.
57. Abu Lila A.S., Kizuki S., Doi Y., Suzuki T., Ishida T., Kiwada H. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. J Control Rel 2009, 137:8-14.
58. Wu J., Lee A., Lu Y., Lee R.J. Vascular targeting of doxorubicin using cationic liposomes. Int J Pharm 2007, 337:329-335.